我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
9
3 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2018
进行中（未招募）
1
11.1%
已完成
2
22.2%
尚未招募
招募中
3
33.3%
Unknown
暂无批准数据
- Singapore launched a $350 million healthy longevity grand challenge in May 2026 under its RIE2030 framework to extend healthspan and shorten years lived in poor health. - The initiative aims to validate biological age clocks and biomarkers for Asian populations, enabling primary care doctors to detect cognitive and physical decline before symptoms appear. - Alexandra Hospital's year-long programme demonstrated measurable improvements in biomarkers, fitness, and biological age through personalised lifestyle interventions rather than high-tech quick fixes. - Researchers are testing precision geromedicine interventions, including low-dose rapamycin and multivitamins, while embedding lifestyle medicine into the medical curriculum to democratise longevity care.
